David L. Barker - 11 Jun 2025 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role: Director
Signature: /s/ Jonathan V. Dixon, Attorney-in-Fact
Issuer symbol: BNGO
Transactions as of: 11 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 12 Jun 2025, 16:50:28 UTC
Previous filing: 25 Feb 2025
SEC: View on sec.gov

Quoteable Key Fact

"David L. Barker filed Form 4 for Bionano Genomics, Inc. (BNGO) on 12 Jun 2025."

Quick Takeaways

This page summarizes David L. Barker's Form 4 filing for Bionano Genomics, Inc. (BNGO).
1 reported transaction and 1 derivative row are listed below.
Filing timestamp: 12 Jun 2025, 16:50.

What Changed

Previous filing in this sequence was filed on 25 Feb 2025.
Current net transaction value: $0.

Why This Matters

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
BARKER DAVID L	Director	C/O BIONANO GENOMICS, INC., 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO	/s/ Jonathan V. Dixon, Attorney-in-Fact	12 Jun 2025	0001189124

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BNGO	Stock Option (Right to Buy)	Award	$0	+2,775		$0.000000	2,775	11 Jun 2025	Common Stock	2,775	$3.67	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan).

Content

The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan).